We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.98B
AUM Growth
+$571M
Cap. Flow
-$47.4M
Cap. Flow %
-0.79%
Top 10 Hldgs %
19.2%
Holding
234
New
18
Increased
64
Reduced
133
Closed
5

Top Sells

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$23M
2
XPO icon
XPO
XPO
+$22.3M
3
CB icon
Chubb
CB
+$19.8M
4
LOW icon
Lowe's Companies
LOW
+$17.9M
5
MPC icon
Marathon Petroleum
MPC
+$9.7M

Sector Composition

Rank Sector Weight
1 Financials 19.44%
2 Healthcare 16.02%
3 Technology 15.43%
4 Industrials 9.43%
5 Communication Services 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
26
Coca-Cola
KO
$375B
$77.1M 1.29%
1,211,646
-56,004
-4% -$3.38M
LOW icon
27
Lowe's Companies
LOW
$125B
$77M 1.29%
386,401
-89,322
-19% -$17.9M
BX icon
28
Blackstone
BX
$110B
$74.9M 1.25%
1,009,541
-73,632
-7% -$6.36M
IFF icon
29
International Flavors & Fragrances
IFF
$21.9B
$74.9M 1.25%
713,980
+161,316
+29% +$15.9M
EOG icon
30
EOG Resources
EOG
$70.7B
$74.1M 1.24%
571,847
-44,337
-7% -$5.9M
ORCL icon
31
Oracle
ORCL
$423B
$72.9M 1.22%
892,459
-78,435
-8% -$5.96M
STZ icon
32
Constellation Brands
STZ
$23.2B
$72.8M 1.22%
314,133
-96,029
-23% -$23M
CMCSA icon
33
Comcast
CMCSA
$90B
$72.5M 1.21%
2,074,541
+627,070
+43% +$20.7M
GSK icon
34
GSK
GSK
$106B
$72.2M 1.21%
2,054,097
+464,538
+29% +$15.5M
CVS icon
35
CVS Health
CVS
$122B
$72M 1.2%
772,855
+22,537
+3% +$2.17M
BUD icon
36
AB InBev
BUD
$165B
$71.6M 1.2%
1,191,833
+257,501
+28% +$13.8M
CHTR icon
37
Charter Communications
CHTR
$18.2B
$71.3M 1.19%
210,150
+58,444
+39% +$20.5M
EQIX icon
38
Equinix
EQIX
$103B
$70.5M 1.18%
107,635
-3,465
-3% -$2.14M
USB icon
39
US Bancorp
USB
$99.6B
$70.3M 1.18%
1,612,262
+100,278
+7% +$4.29M
JNJ icon
40
Johnson & Johnson
JNJ
$625B
$70M 1.17%
396,497
+36,277
+10% +$6.26M
SHEL icon
41
Shell
SHEL
$245B
$69M 1.15%
1,210,757
-73,093
-6% -$4.03M
AMT icon
42
American Tower
AMT
$80.4B
$66.9M 1.12%
315,886
+8,322
+3% +$1.73M
HON icon
43
Honeywell
HON
$78B
$66.3M 1.11%
328,430
-6,005
-2% -$1.15M
ILMN icon
44
Illumina
ILMN
$28.4B
$61.7M 1.03%
313,493
-13,965
-4% -$2.89M
MRK icon
45
Merck
MRK
$318B
$59.7M 1%
538,132
-31,234
-5% -$3.19M
IR icon
46
Ingersoll Rand
IR
$33.7B
$59.1M 0.99%
1,131,918
+31,075
+3% +$1.59M
TDG icon
47
TransDigm Group
TDG
$67.7B
$58.9M 0.98%
93,525
+990
+1% +$583K
TFC icon
48
Truist Financial
TFC
$64B
$54.4M 0.91%
1,263,422
+117,573
+10% +$5.16M
AL
49
DELISTED
Air Lease Corp
AL
$51.3M 0.86%
1,336,076
-30,349
-2% -$1.09M
DIS icon
50
Walt Disney
DIS
$181B
$50.7M 0.85%
583,094
-8,005
-1% -$766K

Similar funds

Douglas Lane & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Douglas Lane & Associates held 234 positions worth $5.98B, up 11% from $5.41B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Douglas Lane & Associates's Q4 2022 filing shows 18 new, 64 increased, 133 reduced and 5 closed positions. Its largest new stake was Alcoa: 353,426 shares worth $16.1M. The largest sale was Constellation Brands, an estimated $23M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Douglas Lane & Associates's largest Q4 2022 buy was Alcoa: 353,426 shares worth $16.1M.
  • Douglas Lane & Associates added most to Haleon in Q4 2022, an estimated $23.3M increase.
  • Douglas Lane & Associates's biggest Q4 2022 reduction was Constellation Brands, cutting an estimated $23M.
  • Douglas Lane & Associates fully exited AvalonBay Communities in Q4 2022, selling an estimated $244K.
  • Douglas Lane & Associates's ten largest holdings make up 19% of its $5.98B portfolio in Q4 2022.
  • Douglas Lane & Associates opened 18 new positions and closed 5 in Q4 2022.
  • Douglas Lane & Associates's portfolio value rose 11% quarter-over-quarter to $5.98B.

Based on Douglas Lane & Associates's 13F filing for Q4 2022, filed 17 Jan 2023.